Health Catalyst Inc

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Health Catalyst Inc reports solid 2022 performance and eyes margin growth opportunities

Health Catalyst Inc delivered strong financial performance in 2022, with revenue growth, improved EBITDA, and a positive outlook for 2023. The company's focus on client relationships, tech-enabled services, and margin improvement positions it well for future success. Challenges such as long sales cycles and migration costs are being managed strategically to drive growth.

Health Catalyst beats Q1 revenue targets, eyes tech-enabled growth

Health Catalyst's Q1 2023 performance showed revenue growth and operational efficiency, with a focus on recurring revenue and client relationships.
While facing challenges in the health system market and revenue lumpiness, the company aims for growth through tech-enabled services and cost-saving strategies.
Opportunities lie in expanding into the ambulatory space, offering modular solutions, and investing in tech capabilities for long-term differentiation and client value.
Overall, Health Catalyst remains cautious about expansion, prioritizing being a differentiated long-term partner to effectively deliver for clients.

Health Catalyst beats Q2 expectations, eyes growth in managed services

Health Catalyst's Q2 performance exceeded expectations, with raised guidance for 2023.
Focus on tech-enabled managed services and long-term client relationships driving growth.
Challenges include longer sales cycles and improving gross margins in contracts.
Opportunities lie in margin improvement, summit impact on bookings, and clinic operations.

Health Catalyst Inc beats Q3 revenue, eyes strong Q4 bookings

Health Catalyst Inc (HCAT) exceeded revenue expectations in Q3 2023 and raised full-year guidance, with strong bookings performance.
The company is focusing on optimizing costs, anticipating a large bookings quarter in Q4 2023.
Recognized for team member engagement and client success stories, with a healthy cash position.
Anticipating growth opportunities in professional services and tech-enabled managed services contracts.

Health Catalyst exceeds Q4 revenue targets, eyes sustainable growth

Health Catalyst Inc's Q4 2023 earnings call highlighted strong financial performance, exceeding revenue and EBITDA guidance, with a focus on client growth and retention.
The company's strategic objectives include migrating clients to a next-gen data platform, balancing growth between tech and services, and driving profitability through operational efficiency.
While facing challenges in client migration and balancing growth, Health Catalyst is well-positioned to capitalize on opportunities like the next-gen platform rollout and cross-selling efforts.
Overall, Health Catalyst's performance, strengths, challenges, and opportunities indicate a strategic focus on sustainable growth, profitability, and enhancing client relationships.

Health Catalyst surpasses Q1 expectations, eyes tech-driven growth

Health Catalyst demonstrated financial resilience and client-centric approach in Q1 2024.
Strategic focus on technology and services to drive growth and avoid limitations.
Opportunities in adjacent markets and client engagement for sustained expansion.
Challenges include managing R&D expenses and potential disruptions from external factors.

Health Catalyst surpasses Q2 revenue targets, eyes growth opportunities

Health Catalyst's Q2 2024 performance exceeded expectations, showcasing strong revenue and margin metrics.
The company's strategic strengths lie in client recognition, acquisitions, platform migration progress, and growth outlook.
Challenges include client retention, revenue growth, margin optimization, and disciplined capital deployment.
Opportunities for Health Catalyst include leveraging financial strength, cross-selling, technology focus, and Ignite platform benefits.

Health Catalyst exceeds Q3 expectations, eyes growth through strategic initiatives

Health Catalyst Inc's Q3 2024 earnings call showcased strong financial performance, positive outlook, and strategic initiatives for growth.
The company's focus on client relationships, market demand, and acquisitions positions it well for future success and industry leadership.
While challenges like margin expansion and competition exist, Health Catalyst Inc's strengths and opportunities indicate a promising trajectory.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Health Catalyst, Inc. (NASDAQ:HCAT ) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Adam Brown - IR Dan Burton - CEO Bryan Hunt - CFO Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Jessica Tassan - Piper Sandler Cindy Motz - Goldman Sachs Elizabeth Anderson - Evercore Stephanie Davis - SVB Securities Richard Close - Canaccord Genuity John Ransom - Raymond James Daniel Grosslight - Citi David Larsen - BTIG Dev Weerasuriya - Berenberg Operator Good day, and thank you for standing by. Welcome to the Health Catalyst First Quarter 2022 Earnings Conference Call.

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q1 2022 Results - Earnings Call Transcript

SALT LAKE CITY , May 11, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has acquired ARMUS Corporation, a Silicon Valley-based clinical registry development and data management technology company. ARMUS provides data abstraction, data validation, data management, data submission, and data reporting services to support participation in clinical quality registries for healthcare institutions around the world, including health systems, payers, medical device companies, and premier medical societies.

Health Catalyst Acquires ARMUS; Bolsters Clinical Quality Offering and Outsourced Services

Health Catalyst (HCAT) delivered earnings and revenue surprises of 25% and 3.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Health Catalyst (HCAT) Reports Q1 Loss, Tops Revenue Estimates

SALT LAKE CITY, May 10, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2022.

Health Catalyst Reports First Quarter 2022 Results

SALT LAKE CITY, April 26, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2022 operating results on Tuesday, May 10, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce First Quarter 2022 Operating Results and Host Conference Call on Tuesday, May 10, 2022

SALT LAKE CITY, March 10, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to health care organizations, today announced an expansive, multi-year strategic partnership with Tallahassee Memorial HealthCare (TMH), a private, not-for-profit community healthcare system serving a 17-county region in North Florida and South Georgia. Together, Health Catalyst and TMH will work to implement a strategic, scalable analytics platform that will serve as a single source of truth across the organization's disparate data sources.

Health Catalyst, Tallahassee Memorial HealthCare Team Up to Achieve Sustainable Clinical Improvements

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2021 Results - Earnings Call Transcript

SOUTH JORDAN, Utah, March 01, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2021.

Health Catalyst Reports Fourth Quarter and Year End 2021 Results

SALT LAKE CITY, Feb. 23, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an engagement with Temple University Health System, a major Philadelphia-based academic health system recognized for its work driving medical advances through clinical innovation, pioneering research and world-class education.  Temple Health selected Health Catalyst PowerCosting™, a part of Health Catalyst's Financial Empowerment Suite, to power the healthcare organization's financial transformation while ensuring excellence in clinical outcomes and improvements.

Temple University Health System Selects Health Catalyst's Data Platform to Help Strengthen Financial Performance and Optimize Value-Based Care

SALT LAKE CITY, Feb. 22, 2022 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has entered into a definitive agreement to acquire KPI Ninja, a Lincoln, Nebraska-based provider of interoperability solutions and population health analytics. KPI Ninja's end-to-end technology solution combines the agility of a centralized platform with interoperability and analytic technology.

Health Catalyst Announces Intent to Acquire KPI Ninja

SALT LAKE CITY, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2021 operating results on Tuesday, March 1, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce Fourth Quarter and Full Year 2021 Operating Results and Host Conference Call on Tuesday, March 1, 2022

SALT LAKE CITY and SAN FRANCISCO, Nov. 16, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data, analytics and technology services to healthcare and life sciences organizations, and Datavant, the leader in helping organizations securely connect health data, today announced a strategic partnership to improve research and care delivery with connected health data. The partnership between Datavant and Health Catalyst will enable life sciences and healthcare organizations to exchange tokenized, de-identified data within the recently announced Health Catalyst Research Network™ and Health Catalyst Touchstone Match™.

Health Catalyst Partners with Datavant to Expand Access to Clinical Trials as a Care Option for Patients

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2021 Results - Earnings Call Transcript

SALT LAKE CITY, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2021.

Health Catalyst Reports Third Quarter 2021 Results

Health Catalyst (HCAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Health Catalyst (HCAT) to Report a Decline in Earnings: What to Look Out for

SALT LAKE CITY, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2021 third quarter operating results on Tuesday, November 9, 2021, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce Third Quarter 2021 Operating Results and Host Conference Call on Tuesday, November 9, 2021

This stock had been reporting losses but posted a break-even quarter in the more recent print and that could start a new trend.

Bull Of The Day: Heath Catalyst (HCAT)

SALT LAKE CITY, Aug. 31, 2021 /PRNewswire/ -- August 31, 2021 – Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced Matt Revis will join the Health Catalyst leadership team. Revis will report directly to Health Catalyst Chief Operating Officer Paul Horstmeier.

Matt Revis Joins Health Catalyst Leadership Team

ALBUQUERQUE, N.M. and SALT LAKE CITY, Aug. 24, 2021 /PRNewswire/ -- Twistle by Health Catalyst, Inc. (Nasdaq: HCAT) ("Twistle"), a leader in patient engagement technology, is now being used to support obstetric services for patients in Northeastern New Mexico.

Twistle and ROAMS Partner to Improve Access to Prenatal Care

SALT LAKE CITY, Aug. 12, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced an expansive, multi-year partnership with Oklahoma Heart Hospital (OHH), one of the largest cardiovascular networks in the United States. Initially, Health Catalyst and OHH will work to accelerate the organization's efforts to improve revenue cycle analytics and performance, drive transparency on the cost of care, and empower clinicians with the right data to inform their patient care delivery processes.

Health Catalyst, Oklahoma Heart Hospital Team Up to Accelerate Cost-Management Transformation and Improved Patient Outcomes

SALT LAKE CITY, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”) (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the pricing of an underwritten public offering of 4,245,283 shares of its common stock at a public offering price of $53.00 per share. The gross proceeds to Health Catalyst from the offering are expected to be approximately $225.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Health Catalyst. In addition, Health Catalyst has granted the underwriters a 30-day option to purchase up to an additional 636,792 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares to be sold in the offering are being offered by Health Catalyst. The offering is expected to close on or about August 13, 2021, subject to satisfaction of customary closing conditions.

Health Catalyst Announces Pricing of Public Offering of Common Stock

SALT LAKE CITY, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”) (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the commencement of an underwritten public offering of $225.0 million of shares of its common stock. All of the shares in the offering are being sold by Health Catalyst. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, Health Catalyst intends to grant the underwriters a 30-day option to purchase up to $33.75 million of shares of its common stock in the public offering at the public offering price.

Health Catalyst Announces Proposed Public Offering of Common Stock

Catalyst, Inc. (HCAT) CEO Dan Burton on Q2 2021 Results - Earnings Call Transcript

ALBUQUERQUE, N.M. and SALT LAKE CITY, Aug. 6, 2021 /PRNewswire/ -- Twistle by Health Catalyst, Inc. (Nasdaq: HCAT) ("Twistle"), a secure communication platform that engages patients in their care, will host a variety of activities at the HIMSS21 Global Conference, including product demonstrations, a Pinksocks giveaway, and a Theater Presentation with Tom Burton, Director of Operations, Orthopedic and Neurosciences at Providence's Southern California Region.

Twistle by Health Catalyst Showcases Innovative Ways to Eliminate Disparities in Care at HIMSS21

Health Catalyst (HCAT) delivered earnings and revenue surprises of 100.00% and 5.20%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

News for Health Catalyst Inc Stock (HCAT)